2016 FALL SESSION - FLASCO / The Voice of Oncology in … · 2016-11-02 · 2016 . FALL SESSION ....

FLORIDA SOCIETY OF CLINICAL ONCOLOGY

2016

FALL SESSION Friday, November 4th

& Saturday, November 5th

Marriott World Center Orlando

2016 FLASCO Fall Session

Conference Agenda Track 1 Patient Navigator

Track 2 Multi-Disciplinary

Track 3 Pharmacy

Track 4 Nursing

Thursday, November 03, 2016

7:00 pm – 9:00 pm

Diamond Events Room Assignment

NON CME EVENT

Celgene West Indies

Merck St. Thomas

Heron Therapeutics Puerto Rico

Bayer Grand Cayman

Sandoz, Inc. Key Biscayne

Friday, November 04, 2016

7:00 am – 9:00 am

Diamond Events Room Assignment

NON CME EVENT

Astellas West Indies

Genentech BioOncology St. Thomas

Pfizer Biosimilars Puerto Rico

Pfizer Grand Cayman

Teva Oncology Key Biscayne

9:00 am – 12:00 pm

FLASCO Board Meeting Aruba/Bahamas

12:00 pm – 2:00 pm

Diamond Event Room Assignment

NON CME EVENT

Takeda Oncology West Indies

Amgen St. Thomas

Lilly Puerto Rico

Bristol Myers Squibb Grand Cayman

Alexion Key Biscayne

Novartis Key Largo

2:00 pm – 4:00 pm

NON CME EVENT

FLASCO Board Group 1: Platinum Corporate Members Key West

FLASCO Board Group 2: Platinum Corporate Members Aruba

FLASCO Board Group 3: Platinum Corporate Members Bahamas

6:00 pm – 7:30 pm

Cash Bar/Visit Exhibits Sawgrass/Vinoy

7:30 pm – 9:30 pm

Dinner & Program (Harbor Beach/Marco Island) Welcome

Michael Diaz MD Florida Cancer Specialists │ FLASCO President

Diana Jordan Author & Professional Speaker The Healing Power of Laughter

Saturday, November 05, 2016 7 : 0 0 a m Registration/Breakfast/Visit Exhibitors Sawgrass/Vinoy

8 : 0 0 a m

Opening Remarks & FLASCO Support Recognition (Harbor Beach/Marco Island) Luis Raez MD FACP FCCP Memorial Cancer Institute │ FLASCO Fall Session Conference Chair

8 : 3 0 a m – 9:30 am

General Session Moderator: Luis Raez MD FACP FCCP

Companion Diagnostics: Unlocking the door to better market access?

The role of NGS in blood Edgardo Santos MD Lynn Cancer Institute

Circulating Tumor Cells (CTC) and exosomes Jhanelle Gray MD Moffitt Cancer Center

Free DNA and free mRNA in plasma for diagnosis and monitoring Tarek Mekhail MD MSc FRCSI FRCSEd Florida Hospital

9 : 3 0 a m Break/Visit Exhibitors Sawgrass Vinoy

1 0 : 1 5 a m – 11:45 am

MULTI-DISCIPLINARY (Harbor Beach/Marco Island)

PHARMACY (Key Largo)

NURSING (Key West)

PATIENT NAVIGATOR (West Indies/St. Thomas)

MELANOMA

Moderator: Eric Harris DO Florida Cancer Specialists

Medical: Jose Lutzky MD Mount Sinai Medical Center

Surgical: Jonathan Zager MD Moffitt Cancer Center

Radiation: Nikhil G Rao MD Florida Hospital

Pathology: Paul M Rodriguez- Waitkus MD PhD University of South Florida

Case Study: Tabitha Townsend MD Fellow, University of Florida

Welcome Jorge J. García, PharmD, MS, MHA, MBA

Memorial Healthcare System Moderator: Gene Wetzstein

PharmD BCOP C.Ph. Moffitt Cancer Center

Antimicrobial Stewardship in Oncology Care

Aliyah Baluch MD MSc FACP University of South Florida Morsani College of Medicine

Rod Quilitz PharmD BCOP Moffitt Cancer Center

Welcome Ana Espinosa DNP MBA RN OCN

Memorial Cancer Institute Cancer Genetics, Genomics,

& Pharmacogenetics Moderator: Mayra Lima MSN

ARNP FNP-C University of Miami

Jeff Weitzel MD City of Hope California

Kathleen Blazer EdD MS LCGC City of Hope California

Welcome Shannon Luker RNOCN CBCN

CN-BN Parrish Medical Center

Moderator: Del Butler RN CBHN BSHSA CN-BN

Metrics in Navigation Sharon Gentry RN MSN CBCN

CBEC Novant Health: Derrick L Davis Cancer Center

Challenges in Managing Cancer Pain David Craig PharmD BCPS

Moffitt Cancer Center Dina Dumercy PharmD BCPS,BCOP

Memorial Healthcare System Anay Moscu PharmD BCPS BCOP

Baptist Health of Miami

Emerging Immune-Oncology Therapy

Moderator: Cheryl Habaue MSN RN CCRP Memorial Healthcare System

Keith Knutson PhD Mayo Clinic

Psychosocial Distress Resources

Carrie Tompkins Stricker PhD RN AOCN Carevive Systems, Inc.

1 1 : 4 5 a m – 1:15 pm

LUNCH & PROGRAM (Harbor Beach/Marco Island) LUNCH & PROGRAM (West Indies/St. Thomas)

Moderator: Luis Raez MD Memorial Cancer Institute The IASLC Lung Cancer Staging Project: The Forthcoming (Eighth)

Edition of the TNM Classification for Lung Cancer Clinical Pathology: Neil A Abrahams MD, Memorial Healthcare Systems

Moderator: Shannon Luker RN OCN CBCN CN-BN The Art Of Active Listening:

Communicating Emotionally Charged or Difficult News Speaker: Lillie Shockney RN BS MAS

Johns Hopkins University School of Medicine

1 : 3 0 p m - 3:00 pm *Nurse

Navigator Track will Adjourn at

4:00pm

MULTI-DISCIPLINARY (Harbor Beach/Marco Island)

PHARMACY (Key Largo)

NURSING (Key West)

PATIENT NAVIGATOR (West Indies/St. Thomas)

LUNG CANCER Moderator: Edgardo Santos MD

Lynn Cancer Institute

Medical: Tarek Mekhail MD MSc FRCSI FRCSEd Florida Hospital

Surgical: Luis Herrera MD Orlando Health

Radiation: Brad Hoppe MD MPH University of Florida

Case Study: Shefali Gajjar MD University of Miami

Specialty Pharmacy and Oral Chemotherapies

Moderator: Melody Chang RPh BCOP MBA Florida Cancer Specialists

Ray Bailey RPh Florida Cancer Specialists Jorge J. García, PharmD, MS, MHA, MBA Memorial Healthcare System

Survivorship Moderator: Christa Roe MA

BS RN OCN Moffitt Cancer Center

Carrie Tompkins Stricker PhD RN AOCN Carevive Systems, Inc.

Survivorship Panel Moderator: Ana Espinosa DNP MBA RN OCN

Memorial Cancer Institute

Moderator: Danielle Finch ARNP

Mayo Clinic Cynthia Frankel RN OCN

CBCN University of Miami

Smitha R Pabbathi MD Moffitt Cancer Center

Maray Salina ARNP Memorial Hospital

Beth Wittmer, RN OCN Florida Cancer Specialists

Navigating Patients to Clinical Trials

Moderator: Katie Zacher MSN Florida Hospital

Cameron Richardson RN BSN OCN Florida Hospital

BIOSIMILARS Moderator: Caren Hughes

PharmD BCOP Mayo Clinic Florida

Overview & Regulations Philip Johnson MS BS Pharm

FASHP Premier Inc.

Clinical and Formulary Consideration & Implementation

Mandy Leonard PharmD BCPS Cleveland Clinic

Hereditary Cancer Testing: The Game has Changed

Moderator: Del Butler RN CBHN BSHSA CN-BN

Jessica McAfee ARNP MSN BC-FNP Bethesda Women’s Health Center

Emerging Immune-Oncology Moderator: Lea Ann Biafora RN

MSN ONN Humana Beacon Oncology Nurse Advocates

Keith Knutson PhD Mayo Clinic

Panel on Access Katie Zacher MSN

Florida Hospital Don Champlain, RN MHA Florida Cancer Specialists

Evania Nichols, MBA Janssen Oncology

The Florida Society of Clinical Oncology

Welcomes You

To the

FLASCO Fall Session

Friday, November 4, 2016

Dinner & Program

Michael Diaz, MD President, Florida Society of Clinical Oncology Executive Board and Director of Patient Advocacy, Florida Cancer Specialists Board of Directors, Community Oncology Alliance (COA) BIOGRAPHY:

Michael Diaz, MD joined Florida Cancer Specialists & Research Institute (FCS) in 2011 and currently serves on the FCS Executive Board and as Director of Patient Advocacy for the practice. Dr. Diaz also provides leadership on the Board of Directors for Community Oncology Alliance (COA), serving on the Payment Reform Task Force working to champion Medical Oncology Health Care Reform. In addition, he serves on the Board of Directors and as President for the Florida Society of Clinical Oncology (FLASCO). He is active on the American Society of Clinical Oncology (ASCO) Payment Reform Work Group and was recently appointed to ASCO's Clinical Practice Committee.

Dr. Diaz donates many hours as an active Medical Missionary and has participated in numerous medical missions to Kingston, Jamaica.

Throughout the year FLASCO offers the opportunity for FLASCO member Oncology Focused Trainees to submit applications for Travel Awards. Thank you for your desire to learn! It is our sincere hope that FLASCO is providing a great service to FLASCO’s Associate Members. If you have suggestions to share about how we may better serve

our membership, please do not hesitate to contact the FLASCO office.

2016 Travel Award Recipients ASCO

Susmitha Apuri, MD Moffitt Cancer Center

BIOGRAPHY: Dr. Apuri is a second year hematology/oncology fellow at University of South Florida/Moffitt cancer center. She attended medical school at N.T.R University of Health Sciences, Vijayawada, India and completed her internal medicine residency at University of Miami regional campus in West Palm Beach. She worked as an assistant professor/hospitalist at

Moffitt Cancer Center prior to pursuing fellowship in hematology/oncology.

Jennifer Crozier, MD Mayo Clinic Florida

BIOGRAPHY: Jennifer A. Crozier, MD, is a compassionate physician who is focused on providing patients with high-quality care. Incorporating her background in research along with clear communication, Dr. Crozier educates her patients on their diagnosis and individualized care

plans by utilizing the latest therapies and clinical trials. She works with a team of multispecialty health care providers in order to provide her patients with high-quality comprehensive care. Her goal is to educate each patient about their disease and answer any questions that may arise during such a life-changing diagnosis as cancer. She has a strong internationally recognized research background and stays up-to-date on the latest cancer research so she can utilize the best novel therapies and clinical trials to provide treatment options. Her areas of expertise include breast cancer and clinical trials.

Bhagirathbhai Dholaria, MBBS Mayo Clinic Florida

BIOGRAPHY: Bhagirathbhai (Bhagi) Dholaria, MBBS is a final year fellow- hematology & oncology, at Mayo Clinic, Jacksonville, FL. He is originally from a small costal town in Western India. He graduated from B. J. Medical College, Ahmedabad, India in 2009 and finished his

Internal Medicine residency from University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR in 2014 and joined Mayo Clinic for his hematology & oncology fellowship. He intends to pursue a carrier in malignant hematology.

Sharon Robertson, MD Moffitt Cancer Center

BIOGRAPHY: Dr. Robertson is a PGY 6 in the Gynecologic Oncology program at the University of South Florida, College of Health. She is a married mother who spent 6 years in Portland, Oregon, before moving to Florida to complete her Oncology Fellowship.

SGO

Erica Takimoto, DO Florida Hospital Cancer Center

STATEMENT: My name is Erica Takimoto and I was the fortunate recipient of the FLASCO travel award in the Spring 2016 prior to completing my fellowship at Florida Hospital in Gynecologic Oncology in July of 2016. The funds provided by the FLASCO travel award

allowed me to attend our National Society of Gynecologic Oncology Annual meeting as well as the Business of Oncology Summit at Gaylord Palms. This afforded me the opportunity to present my research poster at the national SGO meeting, as well as network and connect with our oncology colleagues throughout the state at the FLASCO meeting, where I learned a great deal regarding the business side of oncology. The presentations outlined current changes in business practice, and also what we can expect to be implemented with our ongoing healthcare climate. At the completion of the session, I felt better prepared for the changes to come. There was a wide variety of exhibitors at each Expo center who were excellent resources for information on everything from new drugs and symptom management, to patient clinical registries, better equipping up to take the best possible care of our patients. I am thankful for the opportunity presented by FLASCO, and I am happy to see the ongoing support for young oncology fellows from the state of Florida.

ASTRO

Kamran Ahmed, MD Moffitt Cancer Center

BIOGRAPHY: Kamran Ahmed is a PGY-V radiation oncology resident at Moffitt Cancer Center. He is originally from Houston, TX and then went on to attend Mayo Medical School. After completing his training at Mayo, he went on to complete an internship at Baylor

College of Medicine before beginning his training at Moffitt. He has published numerous peer-reviewed publications during residency with a number of oral presentations at national meetings.

ASCO MACRA Training

Sarah Cevallos, MBA Florida Cancer Specialists

BIOGRAPHY: As Chief Revenue Cycle Officer, Sarah Cevallos is responsible for providing strategic leadership and direction to all Revenue Cycle responsibilities for the Florida Cancer Specialists' physician network. In this role, she supports FCS through excellence in

patient financial services, billing, timely collection, and precise payment posting, while delivering a positive patient experience. Sarah is also responsible for developing our payer partnerships. Since joining FCS in 2008, she has held several finance-related positions of increasing responsibility. Sarah holds a Bachelor of Science degree in Business Management from Nova Southeastern University and an MBA degree from Western Governors University with a concentration in Healthcare Management. In addition to her work with FCS, Sarah serves as Clinical Practice Committee Member for the Florida Association of Clinical Oncology (FLASCO).

ASCO MACRA Training Margarita Wiegandt, MBA Memorial Healthcare Systems

BIOGRAPHY: Maggie Wiegandt has been a healthcare administrator for the past 13 years. In her current role as Vice President of Oncology Services, she is responsible for providing programmatic, operational and strategic leadership to further the growth, improved

outcomes and integration of cancer services within the Memorial Healthcare System in Broward County, the 2nd largest public healthcare system in the nation.

Maggie’s community commitments include Gilda’s Club of South Florida Executive Committee Board Member, Women’s Breast and Heart Initiative Board Member, American Cancer Society Board Member, Pink Angels of the Memorial Foundation Executive Committee Member, and Past Chair of the Board for Miramar/Pembroke Pines Chamber of Commerce. Awards include 1,000 Plus Woman of the Year, Hispanic Woman of Distinction and South Florida Business Journal Up and Comers.

Maggie earned her Bachelor of Science Florida State University and a combined Master of Healthcare Administration and Master in Business Administration from the University of Houston.

ASH

Aixa E. Soyano Muller, MD Mayo Clinic Florida

BIOGRAPHY: Dr. Soyano Muller was born and raised in Caracas, Venezuela in a medically focused family. Both her parents and older brother are physicians, thus she has been interested

in medicine since she was very young. She started her medical education in October 2002 by attending the Luis Razetti School of Medicine at Universidad Central de Venezuela. During Medical school she did a 3-month away rotation in the indigenous community of Wonken, near the Amazon jungle, helping the most needed communities. After graduation she worked as a rural physician as well as a physician assistant in a private hematology practice in Caracas. All these experiences have been enriching and have given her the opportunity to learn to adapt to different environments.

In 2012 she got married and came to the US to start her Internal Medicine Residency Program at St. Elizabeth’s Medical Center in Boston, MA. She graduated in 2015 and moved to Jacksonville to start her Hem/Onc fellowship in July 2015 at Mayo Clinic Florida. In September 2015, she was blessed with having a beautiful baby boy. This last year has been exciting and challenging. She has given love and devotion to her family while at the same time she has been enthusiastic and dedicated to learning and to giving the best medical and humane experience possible to her patients.

Amrita Desai, MD, MPH University of Miami

BIOGRAPHY: Dr. Amrita Desai is currently a third year fellow in the research track in the Department of Hematology/Oncology at the Sylvester Comprehensive Cancer Center, University of Miami. She has a background in Clinical Pharmacology from India and an MPH from Harvard T. H. Chan School of Public Health. Her research is focused in understating the

immunological aspects of hematopoietic stem cell transplant and identifies ways to improve the GVL effects while ameliorating GVHD. Her long long-term career goal is to be a translational researcher in the field of hematopoietic stem cell transplantation.

ASH continued Andrew Kuykendall, MD Moffitt Cancer Center

BIOGRAPHY: Andrew Kuykendall grew up in Tampa, Florida and completed his undergraduate training with a major in economics at Wake Forest University in Winston-Salem, North Carolina. He returned to the state to obtain his medical degree from the University of

Florida in Gainesville followed by a residency in Internal Medicine at the University of South Florida in Tampa. Currently, he is a second year Hematology and Oncology fellow at USF at Moffitt Cancer Center. Dr. Kuykendall is actively involved in research focusing on myeloid diseases, specifically myelofibrosis and other myeloproliferative neoplasms. Throughout his training, he has been actively involved in organized medicine and has served in local leadership roles as well as on national committees for the Florida Medical Association, American Medical Association, and American College of Physicians.

Arjun Mittra, MBBS Mayo Clinic Florida

BIOGRAPHY: Arjun Mittra, MD is currently a fellow in Hematology/ Oncology at the Mayo Clinic in Jacksonville, Florida. After completing medical school in Mumbai, India, Dr. Mittra

pursued postdoctoral fellowships in gastrointestinal and breast cancers at Memorial Sloan Kettering Cancer Center and the University of Southern California. He then trained in Internal Medicine at Presbyterian Hospital Dallas before joining the Mayo Clinic.

In an effort to increase engagement among physicians,

clinicians and administration, the FLASCO Board of

Directors initiated the 100% Membership Program. This

page is to recognize the most recent participating facilities.


MOST RECENT

100% Membership Partners!

Holy Cross Hospital, Michael & Dianne Bienes Comprehensive

Cancer Center is a state-of-the-art facility in Broward County (South Florida) that provides their

physicians with access to national resources to treat all types of cancer, including but not limited to breast

cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer.

Suncoast Cancer Institute is an oncology and hematology practice in Sarasota, Florida,

specializing in the diagnosis and treatment of cancer and blood disorders. Their mission is to improve the

lives of those in their community that are impacted by cancer and blood diseases by providing evidence

based, compassionate, personalized, state of the art care.

Sylvester Comprehensive Cancer Center, University of Miami is a

university-based cancer center. Sylvester physicians and scientists apply research breakthroughs from the

laboratory to the patient’s bedside. Sylvester closely evaluates the effectiveness of new treatments, and

shares clinical insights with laboratory investigators, leading to improvements that benefit patient care.

This type of translational research is the cornerstone of our comprehensive cancer center, providing us the

ability to accurately treat a wide range of cancers across 15 site diseases and from stage one to stage four.

Sylvester patients also have the opportunity to participate in groundbreaking clinical trials that offer new

treatment approaches and help the scientific community answer questions about new ways of using

existing drugs to fight cancer.

Key Note Speaker Diana Jordan Healthcare & Wellness Speaker & Humorist

“The Healing Power of Laughter” OBJECTIVES:

1. Understand ASCO strategies 2. Understand ASCO opportunities 3. Review past victories

BIOGRAPHY: Having entertained over a million people live and on television, Diana Jordan came to realize that by making people laugh, she helped them deal with life's stresses, motivated them, and taught them what she’d learned over the past 25 years about how great laughter is in nourishing yourself and changing your outlook on life.

Diana has toured the country many times over as an extremely successful stand up comedian and successful author. She is also a cancer survivor and speaks of her journey to many cancer organizations and events nationwide. In Diana's Keynote

address, motivational messages ring loud and true about how we can make the choice to be happy, find the funny in your life, taking responsibility for your own health, ways to bust stress and in doing just these four things can make a happier, healthier, and more productive you! And it's funny too!

Diana has been nominated by the American Comedy Awards as one of the Top Five Female Comedians in the country. She's been seen on Showtime, Showtime Specials, HBO, ComedyCentral, VH1, and many more. Diana has also used her talent as a writer in a hilarious best selling book which was featured on Oprah called, "A Wife's Little Instruction Book, Your Survival Guide To Marriage Without Bloodshed!" which has sold over 500,000 copies. Motivational speaking was a natural transition for Diana. She realized her gift and talent for comedy was much needed around the country. For the last two decades Diana has also headlined America's top comedy clubs and entertained our troops overseas. For over a year she performed her widely popular one-woman-show, "Female, Fertile, and Frustrated!" which she Wrote, Produced, Directed, and Starred in at the world famous Ice House Comedy Club in Pasadena, California . "Female, Fertile, and Frustrated!" is still the longest running one person show in the forty year history of The Ice House. No longer FERTILE, Diana makes light of getting older and using humor to cope with being a breast cancer survivor. 'When my Reconstruction Surgeon ask me if I wanted to go up a cup size or two I told him, 'let me put it this way, when I fly I want to be the flotation device!"

Diana studied Improv comedy many years in "Off the wall" classes with classmate Robin Williams (whom she also dated) and has been under contract to the CBS Network and Twentieth Century Fox for her own sit-com which she also wrote and a member of SAG, AFTRA, The National Speakers Association, and The Writers Guild of America. She has opened in concert around the country for major stars as well as at The Kennedy Center, Garden State Arts Center, and Radio City Music Hall. She has also been Master of Ceremonies for many gala events with such prestigious Speakers as Former Secretary of State, General Colin Powell and Yolanda King, daughter of Dr. Martin Luther King.

Diana can also be seen in her co-starring role in "Loretta's Suprise' which was at the Sundance Film Festival and Director Cameron Crowe hand picked her to be in the divorced women's group in the Oscar nominated movie 'Jerry Macguire' with Tom Cruise. You'll see her sitting next to Cruise during the now famous "You complete me" and "You had me at hello" scenes! Cruise says, "Diana is funny and smart, she 'had me at her first joke!"

A world traveler, Diana has lived in Greece, Hawaii, Chicago, Atlanta, Las Vegas, and even ‘starved’ while working as a waitress in New York to get a job on Broadway. She never gives up!

FLASCO Fall Session

Saturday, November 5, 2016 Opening Remarks & General Session

Luis Raez, MD FLASCO Program Chairman & Board Member Director, Memorial Cancer Institute Director, Clinical Oncology Research, Memorial Health Care System Clinical Associate Professor of Medicine, Herbert Wertheim College of Medicine Florida International University

Opening Statements & Moderator

BIOGRAPHY: Luis E. Raez, MD, FACP, FCCP; is the Medical Director of Memorial Cancer Institute (MCI), he is also the Oncology Research Director of Memorial Health Care System (MHS) and Director of the Thoracic Oncology Program. As well as the Clinical Associate Professor of Medicine at Florida International University (FIU) and Visiting Professor of Medicine at Cayetano Heredia University in Peru. Formerly, Dr. Raez was an Associate Professor of Medicine, Epidemiology and Public Health, and a Co-Director of Thoracic Oncology at Sylvester Cancer Center/University of Miami for 10 years (2001-2011). Dr. Raez has expertise in medical oncology in the

areas of lung cancer, and head and neck cancer. Currently Dr. Raez designs phase I-III clinical trials with new chemotherapeutic agents and combinations. Dr. Raez does translational research in the areas of cancer vaccines and has been funded by NCI and the pharma industry. Dr. Raez has given oral presentations and lectures in national and international meetings in the US, Europe, Latinamerica and Asia. He is American Board Certified in: Internal Medicine, Medical Oncology and Geriatric Medicine. He is board elegible in Hematology. Dr. Raez is a member of AACR, ESMO, ASCO, IASLC, ALLIANCE, NCCTG, ACCP, ACP, ACSG, FLASCO among other institutions.

GENERAL SESSION & MULTI DISCIPLINARY TRACK PROGRAM PLANNING COMMITTEE:

Ardeshir Hakam, MD, MBA

Eric Harris, DO

Hank Hill, MD

Randall Henderson, MD, MBA

Thomas Marsland, MD

Shahla Masood, MD

Luis Raez, MD

Edgardo Santos, MD, FACP

Jhanelle E. Gray, MD Associate Member Thoracic Oncology Moffitt Cancer Center

“Evaluation of Circulating Tumor Cells (CTC) and Exosomes in NSCLC: Are we ready for the clinic?”

OBJECTIVES:

1. To gain knowledge of the circulating tumor cell (CTC) assays. 2. To acquire a basic understanding of the role of exosomes.

BIOGRAPHY:

Jhanelle E. Gray, MD, is a Medical Oncologist in the Department of Thoracic Oncology and the Director of Thoracic Clinical Research at H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. She received her undergraduate degree from the University of Florida and her medical degree from Cornell University Medical College in New York City. Following her internship and residency in Internal Medicine at Cornell, Dr. Gray returned to Florida and completed her Medical Oncology Fellowship at Moffitt. She is a faculty member in the Department of Thoracic Oncology at Moffitt Cancer Center where she has been practicing since 2007.

Although Dr. Gray focuses her clinical attentions on lung cancer, she is also deeply involved in clinical research. She is the lead investigator on many thoracic clinical trials especially research investigating novel drug combinations and personalized treatment to advance the fight against lung cancer. As the Director of Thoracic Clinical Research in the Department of Thoracic Oncology, Dr. Gray directly supervises and manages 21 team members, (including 10 clinical research coordinators, 7 research data specialists, and 2 regulatory specialists, a clinical research manager and a clinical research navigator). Dr. Gray leads the restructuring and development of our clinical trial portfolio and assignment (which currently includes 25 clinical trials with active patients and 15 planned clinical trials currently undergoing regulatory and contracts review). In this role, she fosters the clinical trial development through intra- and extramural collaborations between our medical, surgical, and radiation oncologists, research scientists, pathologists, and epidemiologists in the Department of Thoracic Oncology. In addition to treating patients and serving as the lead investigator on many thoracic clinical trials, Dr. Gray is an active member of a number of committees at Moffitt, ranging from evaluation of minority accruals in clinical trials to integration of translational research in Phase I and Phase II clinical trials.

Tarek Mekhail, MD, MSc, FRCSI, FRCSEd Director, Thoracic Oncology Florida Hospital

FLASCO Board Member

“The Role of Liquid Biopsy in the Diagnosis & Management of Lung Cancer”

OBJECTIVES:

1. Identify different technologies for liquid biopsy. 2. Understand the role of liquid biopsy in identifying molecular targets in lung cancer.

BIOGRAPHY:

Tarek Mekhail, MD, a surgeon turned thoracic oncologist, uses his unique background to improve the care he provides to patients at Florida Hospital. By reviewing each case from both a surgical and therapeutic perspective, Dr. Mekhail determines the best treatment approach for each patient’s individual condition. In fact, Dr. Mekhail embraces his role as both doctor and counselor, getting to know each patient personally to develop a lifelong relationship. Through this relationship, he speaks openly and directly about treatment options and life-long care plans.

After attending medical school at Cairo University, he began his medical career as a surgeon in the United Kingdom. Then, Dr. Mekhail completed his medical oncology fellowship at the Cleveland Clinic in Cleveland, Ohio. His transition to oncology took his focus from performing surgery to providing comprehensive care for patients, a duty he takes seriously. In fact, he’ll tell you that the most rewarding difference is seeing the impact his care makes in each patient’s life. Today, Dr. Mekhail leads the Thoracic Oncology Program at Florida Hospital Cancer Institute as medical director and works as an assistant professor at the University of Central Florida. He specializes in treating lung cancer (thoracic cancer), kidney cancer, head/neck cancer and aero-digestive malignancies. As evidence of his dedication to each and every patient’s life-long treatment, Dr. Mekhail has been voted one of the Best Doctors in America for several years in a row.

Edgardo S. Santos, MD, FACP Medical Director of Cancer Research, Thoracic and Head and Neck Cancer Programs, Lynn Cancer Institute Associate Professor of Clinical Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University FLASCO Program Committee Vice Chairman & Board Member

“The Role of NGS in Blood” OBJECTIVES:

1. Understand the indications for liquid biopsy. 2. Apply results from NGS into clinical practice. 3. Understand the methodology of NGS in blood.

BIOGRAPHY: Edgardo S. Santos, MD, FACP, is a well-established thoracic surgeon with an impressive academic career and a remarkably diversified professional journey. Educated in Panama and the United States, he is currently performing at an outstanding level of quality in several key roles across Florida. Dr. Santos is the Medical Director of Cancer Research and Co-leader of the Thoracic and Head & Neck Cancer programs at The Eugene M. & Christine E. Lynn Cancer Institute of Boca Raton Regional Hospital in Boca Raton, Florida. Furthermore, he is a board certified oncologist with the Center for Hematology-Oncology in Boca Raton, Florida, and serves on staff of several local

hospitals, including Bethesda Hospital in Boynton Beach, Florida, and Delray Medical Center in Delray Beach, Florida. Established in 1995, The Center for Hematology-Oncology is on a mission to provide high quality, state-of-the-art, medical care to patients with cancer and blood disorders. Dr. Santos also has an active academic life through his roles as an Affiliate Associate Professor of Biomedical Clinical Medicine at Charles E. Schmidt College of Medicine of Florida Atlantic University. He is a fellow of the American College of Physicians and has held numerous and varied positions throughout his career with well-established education and healthcare providers, such as the University of Miami Leonard M. Miller School of Medicine in Miami, Florida, Tulane University Health Sciences Center - Tulane University School of Medicine in New Orleans, Louisiana, and Southeast Louisiana Veterans Healthcare System, also in New Orleans. Dr. Santos areas of expertise are hematology-oncology, thoracic oncology, and lung cancer. As a hematologist and oncologist, he deals with the diagnosis, prevention, and treatment of various types of malignances, which entails therapy, pathology of cancer in a person, screening, and palliative care. For more information about Dr. Edgardo S. Santos, please visit www.brrh.com or http://centerforhemonc.com.

The Eugene M. & Christine E. Lynn Cancer Institute stands among the largest cancer centers in South Florida. Accredited as a Comprehensive Cancer Center by the American College of Surgeons, The Center works in partnership with the Moffitt Oncology Network, the only National Cancer Institute Comprehensive Cancer Center in Florida, which also secures the Lynn Cancer Institute as one of the top facilities for innovation and excellence. The Lynn Cancer Institute handles the care of more than 3,000 cancer patients each year in facilities such as the Harvey & Phyllis Sandler Pavilion as well as our other respective satellite locations in Delray Beach. Lynn Cancer Center is served by more than 20 oncology physicians and a full complement of oncology professionals on staff. Subsequently, patients receive treatment and services from specialists in genetics, surgery, radiation oncology, medical oncology, pathology and imaging. In addition, the staff includes research nurses, who improve patient access to clinical trials and the most advanced forms of treatment. Lynn Cancer Institute differentiates itself from other similar establishments through its unique approach to multimodality care. “Each multimodality team is comprised of physicians and healthcare professionals who specialize in a specific site of cancer. The team is able to develop standards of care for the specific disease site it treats. These standards reflect the most advanced technology and current treatments available. This simplifies the entire process for our patients, from diagnosis and treatment, to Wellness and Survivorship programs and allows our patients to focus on one thing – recovery”, states the official website of Lynn Cancer Center. For additional information, please visit www.brrh.com.

Edgardo S. Santos, MD, commenced his foray in medicine in 1994 when he acquired his doctorate of medicine from the University of Panama School of Medicine in Panama City, Panama, his native country. He additionally completed his first year of internship at Complejo Hospitalario Metropolitano in Panama City, second year of his internship at Santiago Regional Hospital in Veraguas, Panama, and his internal medicine residency at Complejo Hospitalario Metropolitano. In 1998, Dr. Santos relocated to the United States where he served additional internal medicine internship and residency training at Jackson Memorial Medical Center in Miami, Florida. He also completed fellowship training in hematology and medical oncology at the University of Miami & Jackson Memorial Medical Center, Sylvester Comprehensive Cancer Center. Dr. Edgardo S. Santos is certified in internal medicine and holds sub-specialty certifications in hematology and medical oncology from the American Board of Internal Medicine. A distinguished member of the International Association for the Study of Lung Cancer, he is also a prolific author with many of his works published. Dr. Santos attributes his success to his unwavering dedication and hard work. Furthermore, he has recently been selected by The International Association of HealthCare Professionals (IAHCP) to be published in the premier publication of The Leading Physicians of the World. An avid reader of the Thoracic Oncology Journal, he loves tennis and basketball and devotes his spare time to these two preferred activities. For more information about Dr. Edgardo S. Santos, please visit www.brrh.com or http://centerforhemonc.com.

http://www.brrh.com/

http://centerforhemonc.com/



http://centerforhemonc.com/

FLASCO Fall Session

Lunch & Program

Luis Raez, MD Moderator (See bio on previous page)

Neil A. Abrahams, MD Medical Director for Renal Pathology Service (Native and Transplant) Memorial Healthcare System

“The IASLC Lung Cancer Staging Project: The Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer”

OBJECTIVES:

1. Understand the rationale for the updated staging descriptors for the TNM classification. 2. Integrate the pathologic and the clinical classification of lung cancer in order to understand the

Eighth Edition of the TNM Classification of Lung Cancer. 3. Accurately recognize cases of minimally invasive adenocarcinoma of the lung as described in the

latest classification of lung cancer.

BIOGRAPHY:

Dr. Neil Abrahams is a board-certified doctor of clinical and anatomic pathology. He earned his medical degree from the Universidad de Salamanca Facultad de Medicina in Spain in 1995. He completed his residency at the Akron City Hospital/Summa Health System in Akron, Ohio and at The Cleveland Clinic Foundation in Cleveland in 2002. He completed his fellowship in genitourinary pathology at the University of Texas M.D. Anderson Cancer Center in 2003. Prior to joining Memorial, he served as assistant professor of pathology at the University of Nebraska Medical Center from 2003 to 2006.

Dr. Abrahams is affiliated with Memorial Regional Hospital, Joe DiMaggio Children's Hospital, Memorial Hospital Miramar, Memorial Hospital Pembroke, and Memorial Hospital West.

Lunch & Program Shannon Luker, RN, MHA, OCN, CBCN, CN-BN Moderator (See bio in Navigator handout)

SPONSORED BY:

Lillie Shockney, RN, BS, MAS University Distinguished Professor of Breast Cancer, Adm. Director, the Johns Hopkins Breast Center Adm. Director, Johns Hopkins Cancer Survivorship Programs Departments of Surgery and Oncology Professor, JHU School of Medicine, Departments of Surgery, Oncology and Gynecology Co-founder, JH Medicine’s Managing Cancer at Work

“The Art Of Active Listening: Communicating Emotionally Charged or Difficult News”

OBJECTIVES: 1. To enhance the healthcare professionals communication skills when delivering a new and/or serious diagnosis and handling

difficult questions. 2. To apply empathetic counseling skills with patients facing serious health consequences. 3. To formulate sensitive responses to patients adjusting to or effected by the diagnosis. 4. To support patients so they are better able to understand their medical status and participate in their own care.

BIOGRAPHY: Lillie D. Shockney has been the administrative director of the Johns Hopkins Breast Center since 1997. A two-time breast cancer survivor, Lillie has worked tirelessly to improve the care of breast cancer patients around the world. She is a registered nurse with a Bachelor of Science degree in health care administration from Saint Joseph's College and a Masters in Administrative Science from the Johns Hopkins University. She has worked at Johns Hopkins since 1983. She is also certified as a breast imaging and breast cancer patient navigator. Beginning the end of 2011, she accepted the inaugural role as director of the Johns Hopkins cancer survivorship programs for the Kimmel Cancer Center at Johns Hopkins.

Lillie is a published author and nationally recognized public speaker on the subject of breast cancer. She has written 14 books and more than 250 articles on this subject. She serves on the medical advisory board of several national breast cancer organizations and is the co-founder and vice president of a national non-profit organization called Mothers Supporting Daughters with Breast Cancer.

Lillie is also editor-in-chief of a new peer-reviewed medicine journal called Journal of Oncology Navigation and Survivorship, which launched in Spring 2011. She also serves as the chairman of the Leadership Council of the Academy of Oncology Nurse Navigators (AONN), a national organization that provides a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. This is a professional organization she co-founded in 2009. Beginning in July 2012, she accepted the leadership role of Program Director of AONN.

She is the consultant for breast cancer for national ABC News and Good Morning America, and is also consulted regularly by the Today Show and CNN. She is an active lecturer on various topics related to breast cancer and spoke at the 2010 World Economic Forum, which will featured her lecture, “The Cancer Paradigm Shift: Who Will Take Care of the Breast Cancer Survivors?”.

Lillie serves as “Ask an Expert” for several breast cancer websites, including the Johns Hopkins Breast Center, among others. She also is an active clinical researcher with a focus on quality of life issues for survivors, as well as a strong advocate of the value of humor as a beneficial form of complementary medicine. View Lillie’s online seminar, Breast Cancer Detection and Treatment: What All Women Should Know.

In 2008, the Johns Hopkins Board of Trustees appointed her to a chair as a University Distinguished Service Assistant Professor of Breast Cancer. This is the first time in the history of the institution that a hospital nurse has been appointed to a distinguished service designation. Ms. Shockney has recently been promoted to full professor in the Johns Hopkins University School of Medicine. She is the first nurse in the country to have a primary appointment in the school of medicine and achieved the highest academic rank of full professor in surgery and oncology and also University Distinguished Service Professor of Breast Cancer.

In an effort to increase engagement among physicians, clinicians

and administration (including attendance at events), the FLASCO

Board of Directors agreed to extend complimentary

membership through December 31, 2018 for physicians, nurse

practitioners, physician assistants and office staff from practices,

academic centers and hospitals in the oncology community.


THANKS our

100% Membership Partners!

Broward Health

Cancer Care Centers of Brevard

Cleveland Clinic, Florida

Florida Cancer Specialists

Florida Hospital Gynecologic Oncology

*Holy Cross Hospital, Michael &Dianne Bienes Comprehensive Cancer Center

Mayo Clinic, Florida

Memorial Cancer Institute

Mid Florida Hematology and Oncology

Moffitt Cancer Center

Oncology & Hematology Associates of West Broward

Oncology Resource Networks

Premier Hematology and Oncology

*Suncoast Cancer Institute

*Sylvester Comprehensive Cancer Center at the University of Miami

University of Florida

University of Florida Cancer Center, Orlando Health

Winter Haven Hospital Cassidy Cancer Center

*Recognized on Friday, November 4, 2016, as new 100% FLASCO Member Partners.

2016 FLASCO FALL SESSION

November 4 & 5, 2016

ACCREDITATION STATEMENTS

The Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Medical Educator Consortium designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and implemented in

accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical Educator Consortium and Florida Society of Clinical Oncology. The Medical Educator Consortium is accredited by the ACCME to provide continuing medical education for physicians.

Disclosure Statement: The Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

The Leukemia & Lymphoma Society Approval for nurses has been obtained by the Southern Florida Chapter of The Leukemia & Lymphoma Society under provider number 50-12996 to award up to 6.0 contact hours through the Florida Board of Nursing. This document must be retained by the licensee for a period of four years after the course ends. Do not send to the Florida Board of Nursing. The Florida Society of Clinical Oncology maintains responsibility for this program.

Memorial Regional Hospital

Approval for pharmacists has been obtained by the Memorial Regional Education Program to award up to 3.0 contact hours. The Florida Society of Clinical Oncology maintains responsibility for this program

Revised 6/15 tdv

FACULTY DISCLOSURE (onsite distribution)

FLASCO 2016 FALL SESSION November 4-5, 2016 Orlando, FL The Medical Educator Consortium in accordance with the Standards of Commercial Support of the Accreditation for Continuing Medical Education (ACCME), will disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services by anyone in control of content. As a CME provider decisions in the planning process of this conference were made free of the control of commercial interests. All individuals who are in a position to control the content of this educational activity have disclosed all relevant financial relationships with any commercial interest to the provider. In accordance with the CME Provider’s Conflict of Interest & Resolution Policy, any conflict of interest pertaining to this CME Activity have been resolved. This disclosure includes any all persons in control of content to include staff and educational committee members involved in the planning process. The current definition reads: "A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients." Speakers Luis Raez Grant Research Support: Roche, Pfizer, Astra-Zeneca, Illy, Novartis Edgardo Santos Speakers Bureau: Genentech, Millennium, Celgene, AstraZeneca,

Boehringer Ingelheim, Amgen, Merck, Biodesix, Guardant, Biocept, Caris, Biotheranostics

Jhanelle Gray Grant/Research: Array, AstraZeneca, Merck, Trovagene Consultant: AstraZeneca, Celgene, Eli Lilly, Clovis, Genentech, Boehringer Ingelheim Speaker Bureau: Genentech Tarek Mekhail Grant/Research: Roche/Genentech, AstraZeneca, Lilly, Celgene,

BMS Speakers Bureau: Genentech, Merck, BMS, Boehringer Ingelheim,

Celgene, Lilly Eric Harris Consultant: BMS, Novartis Speakers Bureau: Novartis, Amgen Jose Lutzky Consultant: Novartis Speakers Bureau: Novartis, Merck, BMS Jonathan Zager Grant/Research: Delcath, Amgen, Provectus Consultant: Delcath, Amgen Speakers Bureau: Amgen Nikhil G. Rao Has no relevant financial relationships Paul Rodriguez-Waitkus Has no relevant financial relationships Tabitha Townsend Has no relevant financial relationships Neil A. Abrahams Consultant: Genentech Speakers Bureau: Genentech Stock holder: Pfizer Luis Herrera Consultant: Intuitive Surgical Brad Hoppe Has no relevant financial relationships Shefali Gajjar Has no relevant financial relationships

Revised 6/15 tdv

Planning committee Eric Harris Consultant: BMS, Novartis Speakers Bureau: Novartis, Amgen Diana Jordan Has no relevant financial relationship Ardeshir Hakam Has no relevant financial relationship Hank Hill Speakers Bureau: Myriad Genetics Shahla Masood Has no relevant financial relationships Randall Henderson Has no relevant financial relationships Katrina Williams Has no relevant financial relationships (FLASCO) Dorothy Phillips Has no relevant financial relationships (FLASCO) Julie Newberry Has no relevant financial relationships (FLASCO) Moderator/Planning committee/CME reviewer Luis Raez Grant Research Support: Roche, Pfizer, Astra-Zeneca, Illy, Novartis Edgardo Santos Speakers Bureau: Genentech, Millennium, Celgene, AstraZeneca,

Boehringer Ingelheim, Amgen, Merck, Biodesix, Guardant, Biocept, Caris, Biotheranostics

Teri Valls Has no relevant financial relationships (CME provider)

Each speaker will directly disclose the use of products for which are not labeled (e.g., off label use) or if the product is still investigational.

ALL SPEAKERS HAVE BEEN REQUESTED TO VERBALLY DISCLOSURE PRIOR TO THEIR PRESENTATION AND TO KEEP THEIR PRESENTATION UNBAIS AND GENERIC WHEN

APPLICABLE.

2016 FLASCO Diamond

Corporate Members

Alexion

Amgen

Astellas

Bayer

Bristol-Myers Squibb

Celgene Corporation

Genentech BioOncology

Heron Therapeutics, Inc.

Lilly Oncology

Merck

Novartis Oncology

Pfizer Biosimilars

Pfizer Inc.

Sandoz Inc.

Takeda Oncology

Teva Oncology

PLATINUM AbbVie

AstraZeneca Biodesix, Inc.

bioTheranostics Boehringer Ingelheim

Counsyl Eisai Inc

Foundation Medicine Gilead Sciences, Inc.

Infinity Pharmaceuticals, Inc. Insys Therapeutics, Inc.

Janssen Pharmaceutical Company of J&J Medivation Inc.

Myriad Genetics, Inc. nanoString Technologies

Oncology Supply/ION Solutions Paradigm Diagnostics

Pharmacyclics Sanofi Genzyme Seattle Genetics

Taiho Oncology, Inc. Walgreens

The Florida Society of Clinical Oncology Gratefully Acknowledges & Recognizes the Following

2016 FLASCO Corporate Members:

SILVER ARIAD Pharmaceuticals

Helsinn IPSEN BioPharmaceuticals, Inc.

Spectrum Pharmaceuticals Sysmex

TESARO, Inc.

(As of 10/27/16)

GOLD Clovis Oncology, Inc.

Exelixis, Inc. Incyte Corporation

Merrimack Pharmaceuticals

*AbbVie Agendia *Alexion Pharmaceuticals AMAG Pharmaceuticals *Amgen *ARIAD Pharmaceuticals *Astellas Oncology *AstraZeneca Pharmaceuticals *Bayer HealthCare Pharmaceuticals *Biodesix, Inc. *bioTheranostics, Inc. *Boehringer Ingelheim *Bristol-Myers Squibb BTG International Inc. Cardinal Health *Celgene *Clovis Oncology, Inc. Colon Cancer Alliance *Counsyl *Eisai Inc. Entrinsic Health *Exelixis FLASCO Foundation Florida Cancer Data System *Foundation Medicine *Genentech BioOncology *Gilead Sciences, Inc. Guardant Health *Helsinn Therapeutics Humana *Incyte *Insys Therapeutics Invitae *Ipsen Biopharmaceuticals *Janssen Pharmaceutical Companies of J & J

*Lilly Oncology *Medivation Inc. MedMal Direct Insurance *Merck and Co., Inc. *Merrimack Pharmaceuticals MidaTech Pharma US Inc Moffitt Cancer Center *Myriad Genetics, Inc. *nanoString Technologies *Novartis Oncology *Oncology Supply/ION Solutions *Paradigm Diagnostics *Pfizer Biosimilars *Pfizer Oncology *Pharmacyclics Rpharm-US *Sandoz *Sanofi Genzyme *Seattle Genetics Shire SigmaTau *Spectrum Pharmaceuticals *Sysmex *Taiho Oncology *Takeda Oncology *TESARO, Inc. *Teva Oncology The KEW Group The Leukemia and Lymphoma Society Trovagene University of Florida Health Cancer Center *Walgreens Specialty Pharmacy Winco Mfg., LLC

2016 FLASCO FALL SESSION EXHIBITORS

(as of 10/27/16)

*2016 FLASCO Corporate Members

FLASCO: The Voice of Oncology in FloridaFLASCO: The Voice of Oncology in Florida

November 17, 2016 OncLive State of the Science Summit, West South Beach Hotel,

Miami, FL (FLASCO Co-Sponsored)

January 14, 2017 13TH Annual Clinical Breakthroughs and Challenges in

Hematologic Malignancies, Disney’s Grand Floridian Resort, Lake

Buena Vista, Florida (FLASCO Co-Sponsored)

February 4, 2017 FLASCO’s Annual Puerto Rico Oncology Summit, San Juan

Marriott and Stellaris Casino, San Juan, PR

February 9 - 12, 2017 The 22nd Annual Multidisciplinary Symposium on Breast Disease,

Amelia Island, FL (FLASCO Co-Sponsored)

February 14, 2017 Living with Metastatic Breast Cancer Patient Advocacy Event,

Capital Building, Tallahassee, FL

March 30 - April 1, 2017 FLASCO Spring Session & Business of Oncology, Gaylord Palms,

Kissimmee, FL

May 19 & 20, 2017 Great Strides Together with Rapid Integration Training,

Cleveland Clinic Florida to host, Westin, FL

June 15, 2017 Living with Multiple Myeloma Patient Advocacy Event, Tampa, FL

June 24-25, 2017 Florida Hospital Best of ASCO, Hyatt Grand Regency Cypress,

Orlando, FL (FLASCO Co-Sponsored)

July 14-July 16, 2017 Best of ASCO 2017 Symposium in Miami, JW Marriott Marquis

Miami, Miami, FL(FLASCO Co-Sponsored)

September 30, 2017 Rapid Integration Training, Mayo Clinic Florida, Jacksonville, FL

October 20-21, 2017 FLASCO Fall Session, Renaissance Orlando at Sea World, Orlando,

FL

November 9, 2017 Living with Lung Cancer Patient Advocacy Event, Ft Lauderdale,

FL

April 13-14, 2018 FLASCO Spring Session & Business of Oncology, Tampa Marriott

Waterside Hotel & Marina, Tampa, FL

For more information, please contact: Dorothy Phillips, FLASCO Executive Director

10022 Water Works Lane, Riverview, FL 33578

Office: 813.677.0246 │ Fax: 813.677.0559 │ [email protected] Or visit: www.FLASCO.org

FLORIDA SOCIETY OF CLINICAL ONCOLOGY

SAVE THE

DATES

http://www.dreamstime.com/royalty-free-stock-photo-join-us-image16751415

FLASCO: The Voice of Oncology in FloridaFLASCO: The Voice of Oncology in Florida

THE FLORIDA SOCIETY OF CLINICAL ONCOLOGY

BUSINESS OF ONCOLOGY SUMMIT March 31, 2017

Gaylord Palms Convention Center

6000 West Osceola Parkway, Kissimmee, FL 34746

G ain cutting-edge perspectives on how DISRUPTIONS in healthcare

policy will affect your oncology practice and the care of patients.

Examine how VALUE is defined at the patient, provider, payer, industry, and

national levels. Understand how ALTERNATIVE PAYMENT MODELS, and

MERIT-BASED INCENTIVE PAYMENT SYSTEMS affect the patient,

payer, community oncology practices, cancer

centers, hospitals and industry. Consider the

AFFORDABILITY DEBATE of Healthcare

Rationing: Can it happen here? Can we afford

it?

Disruption as the Driver for

Innovation and Change

Biopharmaceutical Organizations: Healthcare Professionals:

Marketing

Market Access

Sales

Clinical Liaisons

Medical Affairs

Government Affairs

Oncologists

Hematologists

Oncology Physician

Assistants & Nurses

Practice Administrators

Social Workers

Financial Counselors

Patient Advocates

W ho Should Attend?

Please visit www.FLASCO.org for more information.

http://www.flasco.org

7:00—8:00

am REGISTRATION & BREAKFAST

8:00—8:45

am

Welcome & Keynote

Speaker

Disruption as a

driver for

innovation and

change in today’s

environment.

Harold Miller (Confirmed)

Center for Healthcare Quality and Payment Reform

8:45—

10:00am

Alternative Payment

Models

Explanation of

APM’s and

discussion from

the different

stakeholder’s

viewpoints.

Bhuvana Sagar, MD (Confirmed)

Cigna

Medical Director Representative (Confirmed)

UnitedHealthcare

William Harwin, MD (Confirmed)

Florida Cancer Specialists

Steve Grubbs, MD (Confirmed)

ASCO

Gail Erentreich (Confirmed)

Cancer Care Centers of Brevard

Karen Fields, MD (Confirmed)


10:00-

10:15am BREAK BREAK BREAK

10:15-

11:30am

Merit-Based Incentive

Payment System

Coping with

MIPPS:

Practice

Improvement,

Quality,

Resource

Utilization,

Meaningful Use

Florida Blue Representative (To Be Invited)

Sybil Green, JD, RPh, MHA (Confirmed)

ASCO

Maggie Wiegandt, MBA (Confirmed)

Memorial Healthcare Systems

Community Oncologist (To Be Invited)

Pharma Benefit Manager (To Be Invited)

Bobby Green, MD (Confirmed)

Flatiron

11:30—

12:30 pm Lunch

“Disruption as a Driver for Innovation and Change”“Disruption as a Driver for Innovation and Change”

2017 Business of Oncology2017 Business of Oncology

Gaylord Palms Convention CenterGaylord Palms Convention Center 6000 West Osceola Parkway, Kissimmee, FL 347466000 West Osceola Parkway, Kissimmee, FL 34746

Meeting Agenda March 31, 2017Meeting Agenda March 31, 2017

12:30pm–

1:45pm Value

A broader discussion of

APM and MIPPS:

How does each

stakeholder define value

and how does it affect

them.

Robert Carlson, MD (Confirmed)

National Comprehensive Cancer Network

VP of Corporate Communications (Confirmed)

Celgene

Bobbi De Cordova-Hanks (Confirmed)

Cancer Warrior

Founder of Bosom Buddies

Bhuvana Sagar, MD (Confirmed)

Cigna

Karen van Caulil, Ph.D. (Confirmed)

Florida Health Care Coalition

John D. Robinson, CEBS (Invited) RobinsonBush, Inc.


Martin Zagari, MD (Confirmed)

Amgen

1:45-2:00pm BREAK BREAK

2:00-

3:15pm

Affordability

Debate

Healthcare Rationing:

Can it happen here?

Can we afford it?

Allen Lichter, MD (Confirmed)

Peter Ellis, MD (Confirmed)

UPMC Cancer Center

Debra Patt, M.D., M.P.H., M.B.A. (Confirmed)

Texas Oncology

Martin Zagari, MD (Confirmed)

Amgen

Michael Kolodziej, MD (Confirmed)

Flatiron Health

Karen Fields, MD (Confirmed)


VP of Corporate Communications (Confirmed)

Takeda Oncology


3:15-

3:30pm

Florida Medicare

Update Update on Medicare

Juan Schaening MD (Invited)

First Coast Service Options

3:30-

3:45pm

Florida Medicaid

Update Updated on Medicaid

Beth Kidder, MPP (Confirmed)

Florida Agency for Healthcare Administration

3:45 –4:00pm OPEN MIC AND ATTENDEE FEEDBACK │ ADJOURN

“Disruption as a Driver for Innovation and Change”“Disruption as a Driver for Innovation and Change”

2017 Business of Oncology2017 Business of Oncology

Gaylord Palms Convention CenterGaylord Palms Convention Center 6000 West Osceola Parkway, Kissimmee, FL 347466000 West Osceola Parkway, Kissimmee, FL 34746

Meeting Agenda March 31, 2017Meeting Agenda March 31, 2017

9th Annual “GREAT STRIDES TOGETHER” 21st Century Oncology Developments for the APP/RN Physician Team Friday, May 19, 2017

Florida Society of Clinical Oncology: The Voice of Oncology in Florida

Beyond Chemo...:

Cleveland Clinic Florida David G. Jagelman MD Conference Center 2950 Cleveland Clinic Blvd. │ Weston, FL 33331

Great Strides Together will feature:

Recent developments in MDS

Understanding Immuno-Oncology

Adherence to Opioid Prescribing

APPs RNs Physicians Medical Students Allied Healthcare Professionals

Rapid Integration Training will feature:

Introduction to Oncology for PAs andNPs new to oncology.

Education and networkingopportunities .

CME/CEU credit opportunities forPhysician Assistants, NursePractitioners, and RNs with an interestin oncology.

FLASCO creation of state-wide initiativeand network of relationships amongPhysician Assistants & NursePractitioners in oncology and otherdisciplines.

Who Should Attend?

Join Dr. Tan and other

expert faculty on Saturday,

May 20th, from 7 am to 2 pm at

Cleveland Clinic, to positively

impact the speed in which YOU

integrate into the oncology

practice setting.

to oncology?

with Rapid Integration Training Saturday, May 20, 2017

A Clinical Team Perspective

Recent advances in Lung cancer treatment

New developments in Lymphoma

Sex Therapy in the Oncology Patient

Venue:

FLASCO Fall Session

November 4&5, 2016

ROSTER OF ATTENDEES

*indicates speaker or moderator (Current as of October 30. 2016)

*Neil Abrahams MD Helios Pathology, LLC

Paul Adams Genentech BioOncology

Robin Adley RN Martin Health Systems

Kamran Ahmed MD Moffitt Cancer Center

Nahla Ahmed PharmD, BCOP Mayo Clinic Florida

Sikander Ailawadhi MD Mayo Clinic

Geethanjali Akula MD Florida Cancer Specialists

Yanet Aleaga Myriad Genetics

Andrew Alfonso Myriad Genetics

Sophia Alfonso Moffitt Cancer Center

Goz Alhir nanoString Technologies

Catherine Andring Helsinn

Susmitha Apuri MD Moffitt Cancer Center

Joanna Armas AstraZeneca

Tom Arnhart PharmD, MS Novartis Oncology

Tyrone Austin TLA Productions

Valerie Awad Colon Cancer Alliance

*Ray Bailey RPh Florida Cancer Specialists

Ravneet Bajwa MD University of Florida

Amy Ball Insys Therapeutics, Inc.

*Aliyah Baluch MD, MSc, FACP Moffitt Cancer Center

Suzette Bannister Novartis Oncology

Allison Barco Boehringer-Ingelheim

Neilda Baron Novartis Oncology

Casity Bartelt Bayer Healthcare

Patricia Bartzokis Holy Cross Hospital

Jack Bennett Genentech

Sharon Berbick Memorial Healthcare System

Barry Berman MD Broward Health Medical Center

Rebecca Bernard Incyte Corporation

Elizabeth Berry ARIAD Pharmaceuticals

Bob Bexley Celgene

Inder Bhutiani MD Winter Haven Hospital

*Lea Ann Biafora RN, MSN, ONN Humana

Amy Bignon Lilly Oncology

Barbara Bittner RN, BSN, OCN Florida Hospital Memorial Medical Center

Brady Blackman Clovis Oncology

Brenton Blake Counsyl, Inc.

*Kathleen Blazer EdD, MS, LCGC City of Hope

Sean Bloodworth Astellas Oncology

Kelly Bodiford Takeda

Jennifer Boliszar Merck Oncology

Anthony Bonafazio Genentech BioOncology

Jeanne Boudreau RN, OCN, CRNI Suncoast Cancer Institute

Gary Bowers MD Jan Bowser Amgen

Douglas Braun PharmD Florida Cancer Specialists

Scott Brock Bristol Myers Squibb

John Brockenshire Bristol-Myers Squib

Anita Brooks RN Broward Health Coral Springs

Jaimee Brow ARNP War Memorial Hospital

Carmen Brownlee Moffitt Cancer Center

Florence Buencosejo ARNP, MSN, OCN Mount Sinai Comprehensive Cancer Center

Leah Burdett Takeda Oncology

Carrie Burgess RN University of Miami Sylvester Comprehensive Cancer Center

*Delmarie Butler RN Good Samaritan Medical Center FCONN

Carrie Byrns RN Holy Cross Hospital

Dotti Cahill RN Lisa Campanella Janssen Pharma Co of J & J

Pat Campbell Amgen

Kevin Carlin Takeda

Sonja Carroll ARNP Florida Hospital

Fall Session Attendees - Continued

(Current as of October 30, 2016) *indicates speaker or moderator

Robert Cassell MD, PhD

Frank Castellano Pharm.D Merck Oncology

Maribel Chambers Medivation

Victoria Chambers Bayer

*Don Champlain RN, MHA Florida Cancer Specialists

*Melody Chang PharmD, BCOP, MBA Florida Cancer Specialists

Chakra Chaulagain MD, FACP Cleveland Clinic

Bridget Chiuchiolo Taiho Oncology

Perry Chohan AstraZeneca

Angela Cieplevicz BTG Interntational

Ian Clarke Merrimack

Patsy Clarke RN Moffitt Cancer Center

Sharon Cohan The Leukemia & Lymphoma Society

Alan Collin MD

Ivette Colon CPhT/RPhT Florida Cancer Specialists

Cathy Consolo Pharmacyclics

Patty Cooper AMAG Pharmaceutical, Inc.

Erica Corcoran MSN, RN, OCN, AOCNS Florida Hospital Caner

Cathy Couch AMAG Pharmaceutical, Inc.

*David Craig PharmD, BCPS Moffitt Cancer Center

Paige Crocus University of South Florida

Kristin Cuccio Alexion

Bryan Culverhouse Genentech BioOncology

Tim Curlee TEVA Oncology

Mark Curran AMAG Pharmaceutical, Inc.

Carlos da Camera Merck Oncology

Jose Davila MD Puerto Rico Association

Debra Dean UF Health Cancer Center

Kacie deBuys Tesaro

Tatiana DeLeon RN

Craig Deligdish MD Omni Healthcare/Oncology Resource Networks

James Delisle Lilly Oncology

Linda Delude Novartis Oncology

Mark Demps Pfizer

Yamile Der RN Osceola Regional Medical Center

Heather DeRue-Biddle Ipsen Biopharmaceuticals

Amrita Desai MD, MPH Sylvestor Comprehensive Cancer Center, University of Miami

Lester Devlin SCIO Management

Bhagirathbhai Dholaria MD Mayo Clinic Florida

*Michael Diaz MD Florida Cancer Specialists

Saray Diaz ARNP Broward Health Coral Springs

Patrick Doherty Sanofi Genzyme Oncology

Brian Donnelly MidaTech Pharma US, Inc.

Michael Dowdell Novartis Oncology

Rebecca Duffield RN Martin Health Systems

Dan Duffy Clovis Oncology

*Dina Dumercy Pharm.D., BCOP, BCPS Memorial Healthcare System

Nikki Earnest RN Boehringer-Ingelheim

Mike Eddy nanoString Technologies

Joel Eisenberg University of South Florida

Dave Elliott Celgene

Carriette Elusma PharmD, BCPS Memorial Regional South Hospital

Craig Englund MD Florida Cancer Specialists

Jason Enlow Pfizer Biosimilars

Justin Enos Paradigm Diagnostics

*Ana Rosa Espinosa DNP, MBA, RN, OCN Memorial Healthcare System

David Ewing Novartis Oncology

Francine Fanning RN Entrinsic Health

Nancy Farfan BSN, RN University of Miami Sylvester Cancer Center

Steven Fein MD

Kevin Feldman ION Solutions

Karen Fields MD Moffitt Cancer Center

*Danielle Finch MS, ARNP Mayo Clinic Cancer Center

Maggie Fischer Sysmex

Kam Fleming Takeda Oncology



Suzy Fleming SigmaTau

Corinne Floyd Janssen Scientific Affairs & Memorial Regional Hospital

Chad Forrey The KEW Group

Jennifer Fowler Lilly Oncology

Kristie Fox PharmD Cancer Specialists of North Florida

*Cynthia Frankel RN, OCN, CBCN University of Miami, Sylvestor Comprehensive Cancer Center

James Fuqua AbbVie

Mary Cay Futo RN, CMR Novartis Oncology

*Shefali Gajjar MD University of Miami

Yogesh Gala, Pharm. D Walgreens Specialty Pharmacy

Jack Gallagher Genentech

*Jorge Garcia PharmD, MS, MBA Memorial Healthcare System

Stephen Gatto Entrinsic Health

Debora Geary RN Unversity of Miami/SCCC

Christine Gegeckas PharmD Lee Memorial Health System Regional Cancer Center

*Sharon Gentry RN, MSN, CBCN, CBEC Novant Health: Derrick L Davis Cancer Center

Karen Genzardi BSN, RN Florida Cancer Specialists

Nadeem Ghali nanoString Technologies

Cliff Gindin Sandoz

Diana Giorgio Pfizer

Len Giuliano Seattle Genetics

Shelly Glenn Florida Cancer Specialists

Sue Ellen Glover RN St. Petersburg General Hospital

Michele Goldberg RN Bethesda Women's Health Center

Rona Goldberg Humana

Eduard Goldenberg Bristol-Myers Squibb

Victor Gonzalez Astellas Oncology

John Gorant Sandoz

Harrish Gowda Mid Florida Hematology & Oncology

Joanna Grabska MD Moffitt Cancer Center

*Jhanelle Gray MD Moffitt Cancer Center

Glenn Greenwood Bristol-Myers Squibb

Lisa Griffin RN, CPSN, OCN Moffitt McKinley Outpatient Center

Shirley Grimes PharmD Moffitt Cancer Center

Jennifer Gruber Helsinn

Terry Gruchow PA-C Moffitt Cancer Center

Jose Guitian Astellas Oncology

Angela Haase nanoString Technologies

*Cheryl Habaue MSN, RN, CCRP Memorial Healthcare System

Dave Hadden Suncoast Cancer Institute

Julia Haines Novartis Oncology

Ardeshir Hakam MD Moffitt Cancer Center

Shelly Hamm Bristol-Myers Squibb

Dale Hansen Sanofi Genzyme Oncology

Sarah Hanson Pfizer

Greg Hargitt Counsyl, Inc.

William Harrer MD Florida Cancer Specialists

*Eric Harris DO Florida Cancer Specialists

J. Darryl Harrison Astellas Oncology

Christin Hart RN Florida Hospital Cancer Institute

Don Heinrich Suncoast Cancer Institute

Penny Heinrich MD Suncoast Cancer Institute

Jean Henderson, RN

Randal Henderson MD, MBA UF Health Proton Therapy Institute

Kelly Hendricks Tesaro

Kristin Hendrix TEVA Oncology

Wally Henriquez Sysmex

*Luis Herrera MD Orlando Health

Lisa Hickman Walgreens Specialty Pharmacy

John Hiemenz MD University of Florida

Hank Hill MD Osceola Regional Medical Center

Aly Hirji Clovis Oncology

Amyn Hirji Helsinn

Melissa Ho Moffitt Cancer Center

Viet Ho Moffitt Cancer Center



Katherine Hogan Rx-To-Go, FCS

Gary Holcomb Pfizer Biosimilars

Charise Holcombe PA-C Genentech BioOncology

Tony Honingford Genentech BioOncology

*Bradford Hoppe MD, MPH University of Florida Health Proton Therapy Institute

Jennifer Horak Myriad Genetics

Heather Horens Florida Cancer Specialists

Michael Houser Boehringer-Ingelheim

Charles Howe Walgreens Specialty Pharmacy

Michelle Hudson Lilly Oncology

*Caren Hughes PharmD Mayo Clinic Florida

Karen Humphreys UF Health Cancer Center

Rose Huro Waters BSN, RN Spectrum Pharmaceuticals

Maen Hussein MD Florida Cancer Specialists

Robin Hutchinson Sanofi Genzyme Oncology

Todd Hutson Eisai

Nate Ide Entrinsic Health Solutions

Stephen Ingram TEVA Oncology

Jayme Ion MSN, RN Memorial Healthcare System

Kirsten Ireson Eisai Oncology

Vincent Iuliani Lilly Oncology

Nancy Janata Celgene

Dominique Jean-Baptiste RN Broward Health

Brett Jensen nanoString Technologies

Kun Jiang MD, PhD Moffitt Cancer Center

*Philip Johnson MS, RPh, FHOPA, FASHP

Tammi Johnson Winco Mfg., LLC

Lauren Johnston Bristol-Myers Squibb

Jen Jones Amgen

*Diana Jordan

Rick Kadile Insys Therapeutics, Inc.

Brad Kalkwarf Amgen

Anju Kandel RN Moffitt Cancer Center

Paula Karagounis RN Moffitt Cancer Center

Barbara Kassman Astellas

Chris Kemp AbbVie

Erin Kennedy University of South Florida

Azeem Khan University of South Florida

Waseem Khan MD Cancer Care of North Florida

Natalia Khrystolubova RPH, BCOP Rx-To-Go Pharmacy

Julie King Clovis Oncology

Sheryl King MSPharm Merrimack

Deborah Kisko RN Pasco Pinellas Cancer Center

Brandin Klein Helsinn

*Keith Knutson PhD Mayo Clinic Florida

Andrew Kowalski University of South Florida

Sandra Kristjanson Amgen

Andrew Kuykendall MD Moffitt Cancer Center

Joseph Ladd PharmD Miami Cancer Institute

Mohamed Ladha ARIAD Pharmaceuticals

Juan Lagomasino AstraZeneca

Marianne Lambertson Entrinsic Health

Stacey Larrison Takeda

Carolyn Lavender ARNP Genentech BioOncology

Dan Leber Celgene

Cindy LeBron Seattle Genetics

Kari Lee nanoString Technologies

Claudia Leon RN Osceola Regional Medical Center

Chris Leonard Ipsen Biopharmaceuticals

*Mandy Leonard Pharm.D., BCPS Cleveland Clinic

Anna Levin AMAG Pharmaceutical, Inc.

Richard Levine MD Moffitt Cancer Center

Nikki Levinson-Lustgarten RN Navy Hospital

Natalie Leyva Nova SE University

Judith Lightsey MD University of Florida

*Mayra Lima MSN, ARNP, FNP-C University of Miami

Shirley Ann Liu RN JFK Comprehensive Cancer Center



Loretta Loftus MD Moffitt Cancer Center

Deeba Lonzo BSN, OCN Suncoast Cancer Institute

Jennie Lucksinger Ipsen Biopharmaceuticals

*Shannon Luker RN, OCN, CBCN, CN-BN Parrish Medical Center

Dave Lusting Celgene

*Jose Lutzky MD Mount Sinai Medical Center

Amy Macalintal Foundation Medicine

Bradley Maller University of South Florida

Shank Manchepalli Clovis Oncology

Stacy Manges Taiho Oncology

Kelly Markey PharmD, BCOP Moffitt Cancer Center

Merry Jennifer Markham MD, FACP UF College of Medicine: Divison of Hematology & Oncology

Alan Marks MD AR Marks Consulting

Josh Marks SCIO Management

Avery Marlett Celgene

Thomas Marsland MD 21st Century

Rona Martin Myriad Genetics

Leyner Martinez PharmD Joe DiMaggio Children's Hospital

Jim Marzec Pfizer

Troy Mason Biotheranostics

Richard Massaro TEVA Oncology

*Jessica McAfee ARNP, MSN, BC-FNP Bethesda Women's Health Center

Lisa McBride Insys Therapeutics, Inc.

Dan McCabe ARIAD Pharmaceuticals

Scott McCallum Pharmacyclics

Jason McDonald Counsyl, Inc.

Erin McDonough DNP, ARNP-C Florida Medical Clinic

Richard McDonough MD Florida Medical Clinic

Jessica McMillan DNP, FNP, ARNP-BC Mayo Clinic, Florida

Terry McNeill RN Good Samaritan Medial Center

Rita Meitzner RN Moffitt Cancer Center

*Tarek Mekhail MD Florida Hospital

Martin Mendiola MD Bristol-Myers Squibb

Gene Menendez Spectrum Pharmaceuticals

Bob Mesaros CVS Specialty

Jennifer Miller RN Moffitt Cancer Center

Jonathan Miller Biotheranostics

Eric Minor Sandoz

Perilyn Mitchell Counsyl, Inc.

Shari Mitchell Genentech Oncology

Arjun Mittra MD Mayo Clinic Florida

Jay Moore Taiho Oncology

Diana Morgan BSN, RN-BC Moffitt Cancer Center

*Anay Moscu Pharm.D, BCPS, BCOP Miami Cancer Institute, Baptist Health South Florida

Ed Mosley Pfizer Biosimilars

Lindley Mosqueda ARNP-C Florida Hospital Cancer Institute

Jasmine Murchison University of South Florida

Gilbert Murimwa University of South Florida

Michele Murray MidaTech Pharma US, Inc.

Santosh Nair MD Mid Florida Hematology & Oncology

Sushma Nakka MD Lakeland Regional Health Hollis Cancer Center

Ford Nelson Exelixis

Peggy Neville RN Baptist MD Anderson

Julie Newberry Florida Society of Clinical Oncology

Ed Newhouse Pfizer

Maria Newport-Jones Heron Therapeutics

Hoyan Ng-Chen PharmD Miami Cancer Institute

*Evania Nichols MBA Janssen Oncology

Deborah Nosotti AOCNP UF Health Cancer Center - Orlando Health

Chris Nunnelee Gilead Sciences

Alai Nuualiitia Gilead Sciences

Cesar Ochoa MD Mayo Clinic

Daniel Odongo PharmD Walgreens Specialty Pharmacy



Mike Olson Novartis Oncology

Sonia Orcutt MD Moffitt Cancer Center

Marcus Outzen Guardant Health

Kristen Oyler Lilly Oncology

*Smitha Pabbathi MD, FACP Moffitt Cancer Center

Cyndi Paluch Taiho Oncology

Ryan Palusak Amgen

Tracey Parrino Lilly Oncology

Shilpa Patel Heron Therapeutics

Daniel Patterson MD, PhD, MRCP, FACP Bethel Blood and Cancer Center, PA

Kimberly Patton Bristol-Myers Squibb

Jincy Paulose MD Novartis Oncology

Susan Payne MedMal Direct Insurance Company

Michael Pelitere Seattle Genetics

Andrea Pena Sylvester Cancer Center

Glenda Pena RN Cancer Care Centers of Brevard

Lilly Perez Shire

Vanessa Perez RN Moffitt Cancer Center

Ashley Perry University of South Florida

Heather Peterson Helsinn

Dorothy Phillips Florida Society Clinical Oncology

Suzi Phillips Suncoast Cancer Institute

Kathy Pickens Foundation Medicine

Kim Pike Flatiron Health

Rosangela Pina RN Osceola Regional Medical Center

Danielle Piseno RN Sylvester Comprehensive Cancer Centers, University of Miami

Nancy Pitruzzello DNP, ARNP Mayo Clinic

Jozory Polanco ARNP Memorial Regional Hospital

Terry Pompey Lilly Oncology

Xiomara Prats Biotheranostics

Brendan Prendergast MD Health First Cancer Inst.

Alexander Quattlebaum University of South Florida

*Rod Quilitz PharmD, BCOP Moffitt Cancer Center

*Luis Raez MD, FACP, FCCP Memorial Cancer Institute

*Nikhil Rao MD Florida Hospital

Glenn Ravelo Helsinn

Patty Rea Lilly Oncology

Deborah Reagan InterCommunity Cancer Center

Azure Reese Exelixis

Mike Reese Medivation

Juliana Reynolds ARNP University of Miami, Sylvestor Comprehensive Cancer Center

Joyce Rich RN Coral Springs Medical Center

Melissa Rich Sanofi Genzyme Oncology

Sania Richards RN Osceola Regional Medical Center

*Cameron Richardson RN, BSN, OCN Florida Hospital Cancer Institute

Robert Richmond AMAG Pharmaceutical, Inc.

Matt Ring Alexion

Doris Rivas RN Broward Health Coral Springs

Roxanne Rivas Gilead Sciences

Nahir Rivera Moffitt Cancer Center

Matt Robinson Novartis Oncology

Twanda Robinson RN University of Florida

Loren Robinson Clanton Astellas Oncology

Juan Rodas First Physician Group

*Paul Rodriguez-Waitkus MD, PhD University of South Florida

*Christa Roe MA, BS, RN, OCN Moffitt Cancer Center

Lewos Ronald Genomic Health

Anita Roque Foundation Medicine

Paul Rosenberg AstraZeneca

Brenda Rzeszutko MSN, ARNP-BC Florida Hospital Cancer Institute

Jen Sabile Amgen

*Maray Salina ARNP Memorial Healthcare System

Marjorie Salomon RN UM Sylvester Cancer Center

Lisa Samerdyke Lilly



Jose Sandoval Sus MD Moffitt Cancer Center

*Edgardo Santos MD, FACP Lynn Cancer Institute

Ryan Sause Florida Hospital

Tony Savine Pfizer

Anna Saylors Bristol-Myers Squibb

Shannon Schanze Counsyl, Inc.

Jessica Scheer Center for Oncology

Colette Schietromo RPharm-US

Deborah Schmitt RN Cancer Care Center of Brevard

Brad Scott Amgen

Teresa Sellner Myriad Genetics

Ahmed Seweid Nova SE University

John Shimkus Bayer Healthcare

*Lillie Shockney RN, BS, MAS Johns Hopkins University School of Medicine

Amanda Shreders MD Mayo Clinic

Evelyn Silva Alexion

Yenia Silva PharmD Memorial Healthcare System

Doe Simons Pfizer

Frank Slater Flatiron Health

Glenn Smith Oncology Supply

Jennifer Snider Amgen

Kathleen Soriano RN Moffitt Cancer Center

Aixa Soyano MD Mayo Clinic Florida

Milan Srivastava Florida Hospital

Jason Starr DO University of Florida

Laura Stearns RD Entrinsic Health

Chad Steelmon Florida Cancer Specialists

Terrie Stewart Shire

Linda Stine Lilly Oncology

Cindy Stockdale Takeda

Bretton Summers Genentech BioOncology

Lisa Syktich TEVA Oncology

Winston Tan MD Mayo Clinic

Jeff Tholen Trovagene

Amanda Thomas Humana

Tamar Thompson Bristol-Myers Squibb

Pam Thoms Merck Oncology

Abuelenen Toaa University of South Florida

*Carrie Tompkins Stricker PhD, RN Carevive Systems, Inc.

Darwin Torres-Portalatin Helsinn

*Tabitha Townsend MD University of Florida

Loraine Tracey Ipsen

Allison Trainor University of Florida Cancer Center - Clinical Trials Office

John Trotter Clovis Oncology

Caitlin Tucker RN, BSN Unversity of Florida

Marie-Eve Tucker PharmD Broward Health Coral Springs

Liz Turner Amgen

Ed Twyford Seattle Genetics

Steve Tyliszczak AstraZeneca

Dave Tyson Seattle Genetics

Robert Van Atta AstraZeneca

Herman van Besien University of South Florida

Magali Van den Bergh MD Moffitt Cancer Center

Gary VanCleave AstraZeneca

Adrienne Vazquez ARNP Memorial Sloan Kettering

Imelda Velayo RN Osceola Regional Medical Center

Dayamis Veliz RN, BSN UM Sylvester Cancer Center

Dayamis Veliz RN University of Miami

Madhavi Venigalla MD Lakeland Regional Health Hollis Cancer Center

Jo Visser Merck Oncology

Josephine Visser RN Merck Oncology

William Vollmer AbbVie

Trinh Vu RN Moffitt Cancer Center

Al Wallace Bayer Healthcare

Andrea Warren-Smith Bristol-Myers Squibb

Mark Wayson AstraZeneca



Sandy Weiss Foundation Medicine

*Jeffrey Weitzel MD City of Hope

Alexandria West ARNP Memorial Cancer Institute

*Gene Wetzstein PharmD, BCOP Moffitt Cancer Center

Kate Wiber Alexion

Claudia Williams RN Memorial Healthcare System

Katrina Williams Florida Society of Clinical Oncology

Teresa Williams RN, MS, CBCN JFK Breast Institute

Todd Willis AstraZeneca

Penny Wilson-Weber Bristol-Myers Squibb

*Beth Wittmer RN, OCN Florida Cancer Specialists

Lynette Woide Genentech

Elizabeth Woodward LPN Florida Cancer Specialists

Brian Wright Paradigm Diagnostics

Clayton Wright Takeda

Derrick Wright AMAG Pharmaceutical, Inc.

Craig Wyatt Incyte Corporation

Charissa Wynn RN Leesburg Regional Medical Center

Ralph Yaniz FLASCO Foundation, Inc.

Colleen Ydo Astellas Oncology

Gilda - Jo Youngblood Miami Cancer Institute

Pam Yurcisin Celgene

*Katie Zacher MSN Florida Hospital

*Jonathan Zager MD Moffitt Cancer Center

Yohanna Zaldumbide RN UM Sylvester Cancer Center

Perla Zambromo ARNP The Center For Hematology-Oncology

Jennifer Ziesmer Janssen Pharma Co of J & J


FLASCO was formed as a statewide 501(c) (3) nonprofit organization committed to facilitating and promoting multidisciplinary efforts to improve patient care in Florida. FLASCO continues to make strides in promoting excellence in care of patients afflicted with cancer and hematologic disorders and leads efforts to respond to policies and legislation that threaten to compromise patient access to quality cancer care. FLASCO is gaining momentum as more professionals use us as the catalyst to develop partnerships, share knowledge, and stand together to demonstrate strength and determination to move forward in the battle against cancer.

FLASCO consists of over 2,100 members that include physicians and their supporting staff, allied healthcare, and industry representatives that represent the oncology professionals of Florida. FLASCO will continue to be recognized as a nationally respected state professional society as we stand together as “the Voice of Oncology in Florida”.

Thank YOU for Attending

2016 FALL SESSION - FLASCO / The Voice of Oncology in … · 2016-11-02 · 2016 . FALL SESSION ....

Documents

Transcript of 2016 FALL SESSION - FLASCO / The Voice of Oncology in … · 2016-11-02 · 2016 . FALL SESSION ....